Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.65 |
| ▸ | LMNA | P02545 | 2/20 | 0.65 |
| ▸ | TSHR | P16473 | 3/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.58 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.58 |
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.49 |
| ▸ | PGR | P06401 | 1/20 | 0.49 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.49 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.49 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | DGKA | P23743 | 2/20 | 0.46 |
| ▸ | USP2 | O75604 | 2/20 | 0.44 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27637046 | 0.98 | ALDH1A1 (0.67) | ALDH1A1LMNATSHRCYP3A4ALOX15 | |
| SCHEMBL8429929 | 0.98 | ALDH1A1 (0.67) | ALDH1A1LMNATSHRCYP3A4ALOX15 | |
| SCHEMBL1006866 | 0.98 | ALDH1A1 (0.67) | ALDH1A1LMNATSHRCYP3A4ALOX15 | |
| SCHEMBL25329633 | 0.98 | ALDH1A1 (0.67) | ALDH1A1LMNATSHRCYP3A4ALOX15 | |
| SCHEMBL817977 | 0.98 | ALDH1A1 (0.67) | ALDH1A1LMNATSHRCYP3A4ALOX15 | |
| SCHEMBL25330787 | 0.98 | ALDH1A1 (0.67) | ALDH1A1LMNATSHRCYP3A4ALOX15 | |
| SCHEMBL514798 | 0.98 | ALDH1A1 (0.67) | ALDH1A1LMNATSHRCYP3A4ALOX15 | |
| SCHEMBL9571592 | 0.98 | ALDH1A1 (0.67) | ALDH1A1LMNATSHRCYP3A4ALOX15 | |
| SCHEMBL514850 | 0.98 | ALDH1A1 (0.67) | ALDH1A1LMNATSHRCYP3A4ALOX15 | |
| SCHEMBL53665 | 0.98 | ALDH1A1 (0.67) | ALDH1A1LMNATSHRCYP3A4ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1997620-A | Ionic liquids comprising nitrogen-containing cations | UNIV YORK (GB) | 2007-07-11 | — | — | CN | claimed |
| CN-1997620-B | Ionic liquids comprising nitrogen-containing cations | UNIV YORK | 2012-10-03 | — | — | CN | disclosed |
| CN-102344379-A | Ionic liquid containing nitrogen-containing cation | UNIV YORK | 2012-02-08 | — | — | CN | disclosed |
| US-7518005-B2 | Water-soluble anti-dandruff compounds and compositions thereof | GALAXY SURFACTANTS LIMITED (IN) | 2009-04-14 | — | — | US | disclosed |
| CN-101316810-A | Ionic liquids | BIONIQS LTD (GB) | 2008-12-03 | — | — | CN | disclosed |
| CN-1997620-A | Ionic liquids comprising nitrogen-containing cations | UNIV YORK (GB) | 2007-07-11 | — | — | CN | disclosed |
| US-20060182696-A1 | Water-soluble anti-dandruff compounds and compositions thereof | GALAXY SURFACTANTS LIMITED (IN) | 2006-08-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060182696-A1 | Water-soluble anti-dandruff compounds and compositions thereof | POLR1C, ETF1, DHCR24 | ALDH1A1 515/4885LMNA 1041/4885TSHR 3877/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.